Cita APA

Spigel, D. R., Dowlati, A., Chen, Y., Navarro, A., Yang, J. C. H., Stojanovic, G., . . . Azambuja, A. A. (2024). RESILIENT Part 2: A Randomized, Open-Label Phase III Study of Liposomal Irinotecan Versus Topotecan in Adults With Relapsed Small Cell Lung Cancer.

Citación estilo Chicago

Spigel, David R., et al. RESILIENT Part 2: A Randomized, Open-Label Phase III Study of Liposomal Irinotecan Versus Topotecan in Adults With Relapsed Small Cell Lung Cancer. 2024.

Cita MLA

Spigel, David R., et al. RESILIENT Part 2: A Randomized, Open-Label Phase III Study of Liposomal Irinotecan Versus Topotecan in Adults With Relapsed Small Cell Lung Cancer. 2024.